Stem Cell Therapy
What Stem Cell Evidence Shows for Knee Osteoarthritis
Stem Cell Malaysia· 7 min read
Knee pain is one of the most common reasons Malaysians over 50 visit an orthopaedic clinic. Climbing stairs at the LRT station, kneeling for prayers, squatting in the kitchen or simply walking around a pasar malam can become uncomfortable when cartilage wears thin. It is no surprise that stem cell injections have become a popular topic in Kuala Lumpur, Penang and Johor Bahru.
But popularity is not proof. This guide walks through what clinical research actually shows for knee osteoarthritis (OA), where the evidence is promising, where it is weak, and how to make a sensible decision.
Why Knee Osteoarthritis Is So Hard to Treat
Osteoarthritis is not just "wear and tear". It involves cartilage breakdown, inflammation of the joint lining, changes in the underlying bone and weakening of supporting muscles. Cartilage has no direct blood supply, so it repairs itself very poorly.
Standard care in Malaysian public and private hospitals usually follows a step-up path:
- Weight management, physiotherapy and quadriceps strengthening
- Pain relief such as paracetamol or topical and oral NSAIDs
- Intra-articular corticosteroid or hyaluronic acid injections
- Knee replacement surgery in advanced disease
Regenerative options such as platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) sit in the gap between injections and surgery. Their appeal is simple: the hope of slowing or reversing damage rather than only masking symptoms.
What Do "Stem Cell" Knee Injections Actually Contain?
The term is used loosely, and that causes confusion. Products offered for knees generally fall into four groups:
| Product type | Source | Contains living stem cells? | Typical evidence level |
|---|---|---|---|
| Bone marrow aspirate concentrate (BMAC) | Patient's hip bone | Small number of MSCs plus other cells | Small trials, mixed results |
| Adipose (fat) derived preparations | Patient's abdominal fat | Variable; often stromal vascular fraction | Small trials, some positive |
| Cultured, expanded MSCs | Patient or donor tissue | Yes, in defined doses | Phase I/II trials, encouraging but limited |
| Umbilical cord or amniotic products | Donor tissue | Depends on processing; many contain no viable cells | Poorly defined; caution advised |
Understanding which category you are being offered is the first step. If you want to compare donor and self-derived options in more depth, our explainer on autologous versus allogeneic stem cells breaks down the differences.
What Clinical Trials Show
Encouraging early findings
Several small randomized and controlled studies from Spain, South Korea, the United States and other places have found that mesenchymal stem cell injections helped reduce knee pain and made movement easier compared to before treatment. In some cases the results were better than those seen with acid. A few of these studies used MRI scans. Showed that cartilage quality or thickness improved in some patients. When researchers looked at doses the groups that received doses of cultured mesenchymal stem cells often had better outcomes than those who got lower doses. This suggests that the amount of cells used might make a difference in how the treatment works.
The important caveats
The picture becomes more cautious when larger and better-designed trials are considered:
- Small sample sizes. Many studies enrol fewer than 100 people, sometimes far fewer, making results unstable.
- Short follow-up. Twelve months is common. OA develops over decades, so long-term benefit remains largely unknown.
- Placebo response. Knee OA pain responds strongly to placebo injections. Without proper blinding, improvements can be overstated.
- Product variation. Cell source, dose, processing and injection technique differ so much between studies that pooling results is difficult.
- Imaging versus symptoms. Some cartilage changes on MRI do not always match how patients feel.
One of the better-known comparative studies, the MILES trial in the United States, compared bone marrow concentrate, microfragmented fat and a corticosteroid injection. It did not find a clear advantage for the cell-based options over the steroid at one year. Results like this remind us that "biologic" does not automatically mean "better".
What Professional Bodies Say
Major orthopaedic and rheumatology organisations have generally taken a careful position. Guidelines from groups such as the American College of Rheumatology and the American Academy of Orthopaedic Surgeons describe the evidence for stem cell injections as insufficient to recommend them as routine treatment for knee OA. Regulators in several countries, including the US FDA, have not approved a stem cell product specifically for knee osteoarthritis.
That does not mean the research is a dead end. It means that stem cell injections are best understood as investigational or emerging for this condition, and that anyone offering them should be transparent about that status.
The Malaysian Context
Malaysia has a growing regenerative medicine sector, and knee treatments are among the most advertised. Prices quoted by private providers vary widely, commonly from a few thousand ringgit for same-day, self-derived preparations to well above RM 20,000 for cultured or donor-derived programmes. Costs typically depend on:
- Cell source and whether cells are cultured in a laboratory
- Number of cells or doses
- Imaging, consultation and follow-up included
- Hospital versus clinic setting
Because cell therapy products fall under regulatory oversight, it is worth understanding the legal framework before committing. Our article on Malaysian NPRA rules for cell and gene therapy products explains what registration and approval mean for patients, and why claims such as "approved" need clarification.
How Does It Compare with PRP and Other Options?
| Option | Evidence for knee OA | Notes |
|---|---|---|
| Physiotherapy and exercise | Strong | First-line, benefits build over time |
| Hyaluronic acid injection | Moderate, debated | Short-term relief for some |
| PRP injection | Moderate, growing | Often 1 to 3 sessions |
| MSC-based injection | Emerging | Highly variable products |
| Total knee replacement | Strong | For advanced disease |
Who Might Reasonably Consider It?
People most often discussed as candidates include those with mild to moderate OA. Those with severe bone-on-bone disease, significant deformity or ligament instability are less likely to benefit, and surgery may remain the more predictable option.
Factors that generally count against treatment include active infection, certain cancers, uncontrolled diabetes, blood-clotting disorders and pregnancy. A qualified orthopaedic surgeon or sports physician should assess your X-rays or MRI before any injection.
Questions to Ask Before You Proceed
- Which exact product will be injected, and where does it come from?
- Is it registered or otherwise permitted under Malaysian regulations?
- Is this being offered as part of an approved clinical trial or as a private service?
- What published, peer-reviewed results support this use for knee OA?
- What are the risks, and what happens if the treatment does not work?
- How many sessions are expected, and what will the total cost be? See our guide on how many stem cell sessions are usually needed.
- Which side effects have been reported? Our overview of stem cell therapy side effects in clinical studies is a helpful starting point.
Protecting Your Knees While You Decide
Whatever you choose, the basics still matter. Losing even 5 kg can noticeably reduce knee load. Strengthening the thighs, improving balance and adjusting footwear all help. If you are travelling for care, Malaysia Healthcare Travel Council-listed hospitals can offer more structured patient pathways, though listing itself does not endorse a specific therapy.
Frequently Asked Questions
Can stem cells regrow knee cartilage?
Some studies show modest improvements in cartilage quality on MRI, but complete regrowth of normal cartilage has not been reliably demonstrated.
Is stem cell therapy better than PRP for knees?
Current evidence does not show a clear advantage for stem cells over PRP, and PRP is usually less costly.
How long do benefits last?
Reported benefits in trials often last 6 to 24 months in responders, but long-term data are limited.
Is it covered by insurance in Malaysia?
Most private insurers do not routinely cover stem cell injections for OA because they are classed as investigational. Check your policy wording.
The Bottom Line
The evidence for stem cell therapy in knee osteoarthritis looks good. Isn't complete yet. Some patients do report pain and better movement especially when using stem cell products that are well defined and carefully dosed. Still we need studies that last longer and are done by different groups to confirm these results. Treat stem cell therapy as an option, not a guaranteed fix. Be clear about what the treatment's where it stands with regulations and how it compares to exercise PRP and surgery. Be honest, about the benefits and the limitations.
Browse more evidence-based guides at Advance Stem Cell to help you prepare informed questions for your doctor.
This article is for general information only and is not medical advice. Consult our licensed Malaysian medical practitioner about your individual condition.
